CIBC Asset Management
SAGE

CIBC Asset Management’s Sage Therapeutics SAGE Stock Holding History

CIBC Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,633
Closed -$229K – 1238
2019
Q3 		$229K Hold
1,633
– – ﹤0.01% 962
2019
Q2 		$299K Hold
1,633
– – ﹤0.01% 858
2019
Q1 		$260K Buy
+1,633
New +$236K ﹤0.01% 901
2018
Q4 		– Sell
-1,633
Closed -$231K – 1124
2018
Q3 		$231K Hold
1,633
– – ﹤0.01% 982
2018
Q2 		$256K Buy
1,633
+341
+26% +$53.5K ﹤0.01% 903
2018
Q1 		$208K Hold
1,292
– – ﹤0.01% 966
2017
Q4 		$213K Buy
+1,292
New +$125K ﹤0.01% 978

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

CIBC Asset Management's SAGE Position: Q4 2019 in Review

CIBC Asset Management sold out of Sage Therapeutics (SAGE) in Q4 2019, closing a stake of 1,633 shares — an estimated $229K sold.

CIBC Asset Management first reported a position in SAGE in Q4 2017 and held it in 7 quarters. The position peaked at $299K in Q2 2019. 267 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

  • CIBC Asset Management reported no remaining Sage Therapeutics position as of Q4 2019 after selling out during the quarter.
  • CIBC Asset Management sold 1,633 Sage Therapeutics shares in Q4 2019, an estimated $229K.
  • CIBC Asset Management first reported a position in Sage Therapeutics in Q4 2017 and held it in 7 quarters.
  • CIBC Asset Management's Sage Therapeutics position peaked at $299K in Q2 2019.
  • 267 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on CIBC Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.